-
Study aim
-
Determining and comparing effect of the combination of "dimenhydrinate with metoclopramide" and "dimenhydrinate with ondansetron" with "dimenhydrinate alone" in the prevention of nausea and vomiting after the surgery
-
Design
-
A randomized double-blinding clinical trial, with the parallel groups
-
Settings and conduct
-
This randomized double-blind clinical trial is carried out at Feyz Hospital in Isfahan. In this study, 160 patients who are candidates for cataract surgery will be admitted and randomly divided into 4 parallel groups. The distilled water, dimenhydrinate-metoclopramide, dimenhydrinate-ondansetron, and dimenhydrinate alone will be prescribed for these four groups half an hour before the induction of anesthesia, respectively.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria include candidates for cataract surgery, the ASA I, II, or III, and stability of hemodynamic status. Exclusion criteria include the history of the motor disease, addicted patients, smoking, allergies to studied drugs, liver, and vestibular disorders, the use of antinausea drugs in the last 24 hours, prolonging the surgery more than 45 minutes.
-
Intervention groups
-
Half an hour before induction of general anesthesia (which includes injection of 1 cc of 1% propofol, 1 μg/kg and 0.15 mg/kg of ketamine) in the control group 2 cc of distilled water, in the first intervention group 0.5 mg/kg dimenhydrinate with 0.1 mg/kg metoclopramide, in the second intervention group 0.5 mg/kg dimenhydrinate with 0.4 mg ondansetron and in the third intervention group 0.5 mg/kg dimenhydrinate will be administered alone.
-
Main outcome variables
-
Severity of nausea; Severity of vomiting; pain intensity; patient satisfaction